|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hendry S, Salgado R, Gevaert T, Russell
PA, John T, Thapa B, Christie M, van de Vijver K, Estrada MV,
Gonzalez-Ericsson PI, et al: Assessing tumor-infiltrating
lymphocytes in solid tumors: A practical review for pathologists
and proposal for a standardized method from the international
immunooncology biomarkers working group: Part 1: Assessing the host
immune response, TILs in invasive breast carcinoma and ductal
carcinoma in situ, metastatic tumor deposits and areas for further
research. Adv Anat Pathol. 24:235–251. 2017. View Article : Google Scholar
|
|
3
|
Governa V, Trella E, Mele V, Tornillo L,
Amicarella F, Cremonesi E, Muraro MG, Xu H, Droeser R, Däster SR,
et al: The interplay between neutrophils and CD8+ T
cells improves survival in human colorectal cancer. Clin Cancer
Res. 23:3847–3858. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jiang Y, Xie J, Huang W, Chen H, Xi S, Han
Z, Huang L, Lin T, Zhao LY, Hu YF, et al: Tumor immune
microenvironment and chemosensitivity signature for predicting
response to chemotherapy in gastric cancer. Cancer Immunol Res.
7:2065–2073. 2019.PubMed/NCBI
|
|
5
|
Galon J, Costes A, Sanchez-Cabo F,
Kirilovsky A, Mlecnik B, Lagorce-Pagès C, Tosolini M, Camus M,
Berger A, Wind P, et al: Type, density, and location of immune
cells within human colorectal tumors predict clinical outcome.
Science. 313:1960–1964. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Swierczak A, Mouchemore KA, Hamilton JA
and Anderson RL: Neutrophils: Important contributors to tumor
progression and metastasis. Cancer Metastasis Rev. 34:735–751.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhao Y, Ge X, He J, Cheng Y, Wang Z, Wang
J and Sun L: The prognostic value of tumor-infiltrating lymphocytes
in colorectal cancer differs by anatomical subsite: A systematic
review and meta-analysis. World J Surg Oncol. 17:852019. View Article : Google Scholar
|
|
8
|
Idos GE, Kwok J, Bonthala N, Kysh L,
Gruber SB and Qu C: The prognostic implications of tumor
infiltrating lymphocytes in colorectal cancer: A systematic review
and meta-analysis. Sci Rep. 10:33602020. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Mori K, Toiyama Y, Saigusa S, Fujikawa H,
Hiro J, Kobayashi M, Ohi M, Araki T, Inoue Y, Tanaka K, et al:
Systemic analysis of predictive biomarkers for recurrence in
colorectal cancer patients treated with curative surgery. Dig Dis
Sci. 60:2477–2487. 2015. View Article : Google Scholar
|
|
10
|
Lakschevitz FS, Hassanpour S, Rubin A,
Fine N, Sun C and Glogauer M: Identification of neutrophil surface
marker changes in health and inflammation using high-throughput
screening flow cytometry. Exp Cell Res. 342:200–209. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Galdiero MR, Bianchi P, Grizzi F, Di Caro
G, Basso G, Ponzetta A, Bonavita E, Barbagallo M, Tartari S,
Polentarutti N, et al: Occurrence and significance of
tumor-associated neutrophils in patients with colorectal cancer.
Int J Cancer. 139:446–456. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Carus A, Ladekarl M, Hager H, Nedergaard
BS and Donskov F: Tumour-associated CD66b+ neutrophil count is an
independent prognostic factor for recurrence in localised cervical
cancer. Br J Cancer. 108:2116–2122. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ilie M, Hofman V, Ortholan C, Bonnetaud C,
Coëlle C, Mouroux J and Hofman P: Predictive clinical outcome of
the intratumoral CD66b-positive neutrophil-to-CD8-positive T-cell
ratio in patients with resectable nonsmall cell lung cancer.
Cancer. 118:1726–1737. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhu B, Luo J, Jiang Y, Yu L, Liu M and Fu
J: Prognostic significance of nomograms integrating IL-37
expression, neutrophil level, and MMR status in patients with
colorectal cancer. Cancer Med. 7:3682–3694. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ye L, Zhang T, Kang Z, Guo G, Sun Y, Lin
K, Huang Q, Shi X, Ni Z, Ding N, et al: Tumor-infiltrating immune
cells Act as a marker for prognosis in colorectal cancer. Front
Immunol. 10:23682019. View Article : Google Scholar
|
|
16
|
Rao HL, Chen JW, Li M, Xiao YB, Fu J, Zeng
YX, Cai MY and Xie D: Increased intratumoral neutrophil in
colorectal carcinomas correlates closely with malignant phenotype
and predicts patients' adverse prognosis. PLoS One. 7:e308062012.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mantovani A, Cassatella MA, Costantini C
and Jaillon S: Neutrophils in the activation and regulation of
innate and adaptive immunity. Nat Rev Immunol. 11:519–531. 2011.
View Article : Google Scholar
|
|
18
|
Fridman WH, Pagès F, Sautès-Fridman C and
Galon J: The immune contexture in human tumours: Impact on clinical
outcome. Nat Rev Cancer. 12:298–306. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Laghi L, Bianchi P, Miranda E, Balladore
E, Pacetti V, Grizzi F, Allavena P, Torri V, Repici A, Santoro A,
et al: CD3+ cells at the invasive margin of deeply invading
(pT3-T4) colorectal cancer and risk of post-surgical metastasis: A
longitudinal study. Lancet Oncol. 10:877–884. 2009. View Article : Google Scholar
|
|
20
|
Pagès F, Kirilovsky A, Mlecnik B, Asslaber
M, Tosolini M, Bindea G, Lagorce C, Wind P, Marliot F, Bruneval P,
et al: In situ cytotoxic and memory T cells predict outcome in
patients with early-stage colorectal cancer. J Clin Oncol.
27:5944–5951. 2009. View Article : Google Scholar
|
|
21
|
Eruslanov EB: Phenotype and function of
tumor-associated neutrophils and their subsets in early-stage human
lung cancer. Cancer Immunol Immunother. 66:997–1006. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Silvestre-Roig C, Hidalgo A and Soehnlein
O: Neutrophil heterogeneity: Implications for homeostasis and
pathogenesis. Blood. 127:2173–2181. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Fridlender ZG, Sun J, Kim S, Kapoor V,
Cheng G, Ling L, Worthen GS and Albelda SM: Polarization of
tumor-associated neutrophil phenotype by TGF-beta: ‘N1’ versus ‘N2’
TAN. Cancer Cell. 16:183–194. 2009. View Article : Google Scholar
|
|
24
|
Fridlender ZG and Albelda SM:
Tumor-associated neutrophils: Friend or foe? Carcinogenesis.
33:949–955. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ng LG, Ostuni R and Hidalgo A:
Heterogeneity of neutrophils. Nat Rev Immunol. 19:255–265. 2019.
View Article : Google Scholar
|
|
26
|
Pillay J, Tak T, Kamp VM and Koenderman L:
Immune suppression by neutrophils and granulocytic myeloid-derived
suppressor cells: Similarities and differences. Cell Mol Life Sci.
70:3813–3827. 2013. View Article : Google Scholar
|
|
27
|
Posabella A, Köhn P, Lalos A, Wilhelm A,
Mechera R, Soysal S, Muenst S, Güth U, Stadlmann S, Terracciano L,
et al: High density of CD66b in primary high-grade ovarian cancer
independently predicts response to chemotherapy. J Cancer Res Clin
Oncol. 146:127–136. 2020. View Article : Google Scholar
|
|
28
|
Huang X, Pan Y, Ma J, Kang Z, Xu X, Zhu Y,
Chen J, Zhang W, Chang W and Zhu J: Prognostic significance of the
infiltration of CD163+ macrophages combined with
CD66b+ neutrophils in gastric cancer. Cancer Med.
7:1731–1741. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wikberg ML, Ling A, Li X, Öberg Å, Edin S
and Palmqvist R: Neutrophil infiltration is a favorable prognostic
factor in early stages of colon cancer. Hum Pathol. 68:193–202.
2017. View Article : Google Scholar
|
|
30
|
Mlecnik B, Tosolini M, Kirilovsky A,
Berger A, Bindea G, Meatchi T, Bruneval P, Trajanoski Z, Fridman
WH, Pagès F and Galon J: Histopathologic-based prognostic factors
of colorectal cancers are associated with the state of the local
immune reaction. J Clin Oncol. 29:610–618. 2011. View Article : Google Scholar
|
|
31
|
Zhu G, Pei L, Xia H, Tang Q and Bi F: Role
of oncogenic KRAS in the prognosis, diagnosis and treatment of
colorectal cancer. Mol Cancer. 20:1432021. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Pylayeva-Gupta Y, Lee KE, Hajdu CH, Miller
G and Bar-Sagi D: Oncogenic Kras-induced GM-CSF production promotes
the development of pancreatic neoplasia. Cancer Cell. 21:836–847.
2012. View Article : Google Scholar
|
|
33
|
Smakman N, Veenendaal LM, van Diest P, Bos
R, Offringa R, Borel Rinkes IH and Kranenburg O: Dual effect of
Kras(D12) knockdown on tumorigenesis: Increased immune-mediated
tumor clearance and abrogation of tumor malignancy. Oncogene.
24:8338–8342. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zdanov S, Mandapathil M, Abu Eid R,
Adamson-Fadeyi S, Wilson W, Qian J, Carnie A, Tarasova N,
Mkrtichyan M, Berzofsky JA, et al: Mutant KRAS conversion of
conventional T cells into regulatory T cells. Cancer Immunol Res.
4:354–365. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Vono M, Lin A, Norrby-Teglund A, Koup RA,
Liang F and Loré K: Neutrophils acquire the capacity for antigen
presentation to memory CD4+ T cells in vitro and ex
vivo. Blood. 129:1991–2001. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Glasser L and Fiederlein RL: The effect of
various cell separation procedures on assays of neutrophil
function. A critical appraisal. Am J Clin Pathol. 93:662–669. 1990.
View Article : Google Scholar
|
|
37
|
Topalian SL, Drake CG and Pardoll DM:
Immune checkpoint blockade: A common denominator approach to cancer
therapy. Cancer Cell. 27:450–461. 2015. View Article : Google Scholar
|
|
38
|
Du X, Liu M, Su J, Zhang P, Tang F, Ye P,
Devenport M, Wang X, Zhang Y, Liu Y and Zheng P: Uncoupling
therapeutic from immunotherapy-related adverse effects for safer
and effective anti-CTLA-4 antibodies in CTLA4 humanized mice. Cell
Res. 28:433–447. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Germann M, Zangger N, Sauvain MO, Sempoux
C, Bowler AD, Wirapati P, Kandalaft LE, Delorenzi M, Tejpar S,
Coukos G and Radtke F: Neutrophils suppress tumor-infiltrating T
cells in colon cancer via matrix metalloproteinase-mediated
activation of TGFβ. EMBO Mol Med. 12:e106812020. View Article : Google Scholar : PubMed/NCBI
|
